scholarly journals Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in Type 1 (insulin-dependent) diabetic patients

Diabetologia ◽  
1989 ◽  
Vol 32 (11) ◽  
Author(s):  
A.J. Scheen ◽  
J. Gillet ◽  
J. Rosenthaler ◽  
J. Guiot ◽  
Ph. Henrivaux ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document